Toward Efficient Trials in Colorectal Cancer: The ARCAD Clinical Trials Program

被引：27
|
作者：
de Gramont, Aimery [1 ]
Haller, Daniel G. [2 ]
Sargent, Daniel J. [3 ]
Tabernero, Josep [4 ]
Matheson, Alastair [5 ]
Schilsky, Richard L. [6 ]
机构：
[1] Hop St Antoine, F-75571 Paris, France
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[3] Mayo Clin, Canc Ctr Stat, Rochester, MN USA
[4] Vall Hebron Univ Hosp, Med Oncol Serv, Barcelona, Spain
[5] Fdn ARCAD, Paris, France
[6] Univ Chicago, Div Biol Sci, Chicago, IL 60637 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 04期
关键词：
FLUOROURACIL PLUS LEUCOVORIN; PROGRESSION-FREE SURVIVAL; INDIVIDUAL PATIENT DATA; END-POINTS; 1ST-LINE TREATMENT; ORAL CAPECITABINE; CRITICAL PATH; COLON-CANCER; IRINOTECAN; DRUG;
D O I：
10.1200/JCO.2009.25.2544
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：527 / 530
页数：4
相关论文
共 50 条
  • [1] The ARCAD Clinical Trials Program: An Update and Invitation
    Sargent, Daniel J.
    Buyse, Marc
    Matheson, Alastair
    Goldberg, Richard M.
    de Gramont, Aimery
    ONCOLOGIST, 2012, 17 (02): : 188 - 191
  • [2] Association of Age With Survival in Patients With Metastatic Colorectal Cancer: Analysis From the ARCAD Clinical Trials Program
    Lieu, Christopher H.
    Renfro, Lindsay A.
    de Gramont, Aimery
    Meyers, Jeffrey P.
    Maughan, Timothy S.
    Seymour, Matthew T.
    Saltz, Leonard
    Goldberg, Richard M.
    Sargent, Daniel J.
    Eckhardt, S. Gail
    Eng, Cathy
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 2975 - +
  • [3] The impact of young age on survival in patients with metastatic colorectal cancer: Analysis from the ARCAD Clinical Trials Program
    Lieu, C.
    Renfro, L.
    De Gramont, A.
    Maughan, T. S.
    Seymour, M. T.
    Saltz, L.
    Goldberg, R. M.
    Sargent, D.
    Eckhardt, S. G.
    Eng, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S483 - S483
  • [4] National Cancer Institute Clinical Trials Program in Colorectal Cancer
    Barbara A. Conley
    Richard S. Kaplan
    Susan G. Arbuck
    Cancer Chemotherapy and Pharmacology, 1998, 42 : S75 - S79
  • [5] National Cancer Institute Clinical Trials Program in colorectal cancer
    Conley, BA
    Kaplan, RS
    Arbuck, SG
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (Suppl 1) : S75 - S79
  • [6] Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First-and Second-Line Clinical Trials
    McCleary, Nadine J.
    Harmsen, William S.
    Haakenstad, Ellana
    Cleary, James M.
    Meyerhardt, Jeffrey A.
    Zalcberg, John
    Adams, Richard
    Grothey, Axel
    Sobrero, Alberto F.
    Van Cutsem, Eric
    Goldberg, Richard M.
    Peeters, Marc
    Tabernero, Josep
    Seymour, Matt
    Saltz, Leonard B.
    Giantonio, Bruce J.
    Arnold, Dirk
    Rothenberg, Mace L.
    Koopman, Miriam
    Schmoll, Hans-Joachim
    Pitot, Henry C.
    Hoff, Paulo M.
    Tebbutt, Niall
    Masi, Gianluca
    Souglakos, John
    Bokemeyer, Carsten
    Heinemann, Volker
    Yoshino, Takayuki
    Chibaudel, Benoist
    deGramont, Aimery
    Shi, Qian
    Lichtman, Stuart M.
    JNCI CANCER SPECTRUM, 2022, 6 (02)
  • [7] Colorectal cancer vaccines in clinical trials
    Speetjens, Frank M.
    Zeestraten, Eliane C. M.
    Kuppen, Peter J. K.
    Melief, Cornelis J. M.
    van der Burg, Sjoerd H.
    EXPERT REVIEW OF VACCINES, 2011, 10 (06) : 899 - 921
  • [8] From Molecular Biology to Clinical Trials: Toward Personalized Colorectal Cancer Therapy
    Palma, Sabina
    Zwenger, Ariel O.
    Croce, Maria V.
    abba, Martin C.
    Lacunza, Ezequiel
    CLINICAL COLORECTAL CANCER, 2016, 15 (02) : 104 - 115
  • [9] Turning point for colorectal cancer clinical trials
    Meropol, Neal J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (21) : 3322 - 3324
  • [10] The Microbiome and Colorectal Cancer: Current Clinical Trials
    Leavitt, Jennifer
    Saleh, Naveed
    ONCOLOGY-NEW YORK, 2019, 33 (02): : 78 - 78
12345